Cannabis Stocks — Analysis & Key Financial Data
Cannabis Stocks bring together companies that share index membership or exposure to a structural theme. Investors often use these baskets to see which constituents currently look strongest on fundamentals, valuation, and quality — and which names may already be priced for perfection. This page shows cannabis stocks with Invest Viable's Investment Scores, base valuations, and key financial data so you can compare constituents side by side. Use it as a transparent screening layer on top of the index or theme, not as a list of recommendations.
- Stocks matching
- 3,190
- Latest data
- 2026-06-28
Highest Investment Scores in Cannabis Stocks
Top-rated stocks by Investment Score
- Price
- $91.19
- Fair Value
- $355.29
- Market Cap
- $21.2B
- Margin
- +289.6%
- Price
- $175.25
- Fair Value
- $263.72
- Market Cap
- $2.3B
- Margin
- +50.5%
- Price
- $41.36
- Fair Value
- $55.84
- Market Cap
- $1.1B
- Margin
- +35.0%
- Price
- $72.34
- Fair Value
- $69.18
- Market Cap
- $5.1B
- Margin
- -4.4%
Cannabis Stock List
| Company | Price | Fair Value | Score | Market Cap | P/E | EPS | Yield |
|---|---|---|---|---|---|---|---|
NVIDIA Corporation NVDA | $194.97 | $103.72 | 74 | $4.66T | 29.4 | $6.57 | 0.15% |
Apple Inc. AAPL | $281.74 | $172.51 | 61 | $4.17T | 34.2 | $8.33 | 0.37% |
Alphabet Inc. GOOGL | $353.65 | $213.22 | 74 | $4.08T | 25.5 | $13.24 | 0.25% |
Alphabet Inc. GOOG | $351.28 | $213.51 | 74 | $4.07T | 25.5 | $13.24 | 0.25% |
Microsoft Corporation MSFT | $368.57 | $319.11 | 81 | $2.77T | 22.1 | $16.86 | 0.95% |
Amazon.com, Inc. AMZN | $240.14 | $86.67 | 71 | $2.50T | 27.4 | $8.45 | 0.00% |
Space Exploration Technologies Corp. SPCX | $164.19 | — | 13 | $2.00T | -130.1 | $-1.24 | 0.00% |
Broadcom Inc. AVGO | $372.45 | $123.06 | 68 | $1.74T | 59.0 | $6.18 | 0.70% |
Tesla, Inc. TSLA | $411.84 | $58.60 | 48 | $1.43T | 315.5 | $1.20 | 0.00% |
Meta Platforms, Inc. META | $562.60 | $637.20 | 74 | $1.40T | 19.7 | $27.86 | 0.38% |
Micron Technology, Inc. MU | $1145.28 | $167.55 | 74 | $1.28T | 25.3 | $44.75 | 0.04% |
Eli Lilly and Company LLY | $1229.93 | $503.90 | 65 | $1.14T | 42.8 | $28.26 | 0.54% |
Berkshire Hathaway Inc. BRK-B | $496.00 | $375.42 | 65 | $1.08T | 14.8 | $33.60 | 0.00% |
Berkshire Hathaway Inc. BRK-A | $744200.00 | $564401.28 | 58 | $1.07T | 14.8 | $33.60 | 0.00% |
Walmart Inc. WMT | $114.60 | $53.77 | 61 | $920.7B | 40.6 | $2.89 | 0.83% |
JPMorgan Chase & Co. JPM | $329.39 | $547.64 | 52 | $881.7B | 15.7 | $21.12 | 1.79% |
Advanced Micro Devices, Inc. AMD | $539.49 | $40.62 | 61 | $850.5B | 169.3 | $3.07 | 0.00% |
ASML Holding N.V. ASML | $1883.11 | $596.00 | 71 | $691.7B | 61.0 | $25.98 | 0.48% |
Intel Corp. INTC | $131.72 | $0.18 | 29 | $644.9B | -207.0 | $-0.62 | 0.00% |
Visa Inc. V | $341.65 | $268.13 | 65 | $644.5B | 29.3 | $11.62 | 0.77% |
Johnson & Johnson JNJ | $258.51 | $140.16 | 65 | $613.0B | 29.4 | $8.60 | 2.06% |
Exxon Mobil Corporation XOM | $136.04 | $141.90 | 65 | $566.0B | 23.1 | $6.05 | 2.99% |
Applied Materials, Inc. AMAT | $694.64 | $242.85 | 65 | $497.7B | 58.6 | $10.72 | 0.30% |
Lam Research Corporation LRCX | $410.91 | $103.59 | 71 | $474.1B | 71.3 | $5.37 | 0.27% |
Caterpillar Inc. CAT | $1033.19 | $456.77 | 61 | $459.5B | 49.4 | $20.33 | 0.61% |
About cannabis stocks
Cannabis is one of the most jurisdictionally fragmented themes in the screener. Companies operating in different countries — and in the US, in different states — face very different regulatory regimes, tax structures, and capital-market access conditions. That fragmentation has produced a listed universe that mixes operators, multi-state platforms, cultivation specialists, retailers, ancillary equipment and software providers, and a smaller set of cannabis-focused REITs. The financial profiles inside vary widely, and the regulatory situation can change the operating environment for the entire segment in ways the typical sector or theme can't experience.
The screener applies the same Investment Score and base-valuation pipeline across this list. Many constituents are small-cap or micro-cap with thinner financial-history coverage than larger names, so some Investment Scores and margins of safety will show "—" rather than estimating where the model lacks sufficient inputs.
What this page is for
This page is a screener and reference surface, not editorial coverage. The list above refreshes with each data update; the methodology, FAQ, and related categories below stay in place so the page is useful both for somebody arriving from a specific search and for somebody scanning the theme for the first time.
If you want to value a single cannabis stock end-to-end rather than scan the theme, the Invest Viable Valuator walks through the same models we use to compute the base valuations on this page.
Where you'll find Cannabis Stocks
This theme typically shows up across the sectors below. Each sector page lists every covered name with the same Investment Score model and base-valuation pipeline.
How we screen Cannabis Stocks
A company appears on this page when our taxonomy classifies its primary business as cannabis — cultivators, processors, retailers, and ancillary providers (real estate, equipment) whose revenue is materially cannabis-tied.
- Listed on a US exchange (NYSE / Nasdaq) and tagged Cannabis in our theme taxonomy.
- Includes US and Canadian multi-state operators (where US listings are available), pure-play cultivators and processors, dispensaries, cannabis-focused REITs, and ancillary equipment and services providers whose primary revenue is cannabis-related.
- Investment Score and base valuation computed by the same models used elsewhere on Invest Viable.
Frequently asked questions
Which companies count as cannabis stocks?
Companies whose primary revenue is cannabis-related — cultivators, processors, multi-state operators, dispensary chains, cannabis-focused REITs, and ancillary providers (cultivation equipment, packaging, point-of-sale software). Pharmaceutical companies with cannabinoid drug programmes typically sit on the Pharma or Biotech pages instead.
How are cannabis stocks valued?
The category mixes cyclical commodity-style cultivation (where pricing has been historically volatile) with branded retail-style operations (where unit economics resemble specialty consumer goods) and asset-heavy REITs (where the conventions match real estate). Our base valuations apply DCF and multiple-based methods; the Investment Score reflects balance-sheet quality which is especially material here.
Why is the regulatory environment relevant?
Cannabis is regulated very differently in different jurisdictions, and US federal classification creates structural complications for capital markets access, banking relationships, and tax treatment that don't apply to most other industries. Companies operating in different regulatory environments aren't directly comparable on every metric. The screener treats them through the same valuation pipeline but the underlying differences remain.
Why do many cannabis stocks have very thin financial coverage?
A meaningful share of the listed cannabis universe is small-cap or micro-cap with shorter operating histories and simplified disclosure schedules. Some names lack the financial depth required to compute a full Investment Score; the page shows "—" rather than estimating in those cases.
Does Invest Viable recommend specific cannabis stocks?
No. This page is a screener and analysis surface, not a recommendation list. Each stock is shown with its underlying financial data, base valuation, and Investment Score so you can do your own research. Invest Viable does not publish buy or sell calls on individual securities.